Form 4: Stereotaxis Inc. Insider Stock Option Grant

Kimberly R. Peery, Chief Financial Officer of Stereotaxis, Inc., was granted 40,000 stock options with an exercise price of $1.87.

Summary

• Kimberly R. Peery, the Chief Financial Officer of Stereotaxis, Inc., received a grant of 40,000 stock options.
• The options have an exercise price of $1.87 per share.
• These options are exercisable starting April 11, 2027, and expire on April 11, 2036.
• The vesting schedule indicates that 25% of the options vest one year after the grant date, with the remaining 75% vesting monthly over the subsequent three years.
• Following this transaction, Ms. Peery beneficially owns 340,750 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a standard executive compensation practice rather than a significant change in company performance or strategy.

Positives

• Grant of stock options to a key executive, aligning their interests with shareholders.
• The exercise price of $1.87 suggests a potential for upside if the stock price increases.
• A structured vesting schedule encourages long-term commitment from the executive.

Negatives

• The filing only details an option grant, not actual stock purchases or sales, which could provide more direct insight into insider confidence.

Risks

• The value of the stock options is contingent on the future performance of Stereotaxis, Inc.'s stock price.
• If the stock price does not exceed the exercise price of $1.87, the options may not be exercised.

Future Outlook

The future outlook for the stock options is dependent on the company's performance and the market's valuation of Stereotaxis, Inc. (STXS). The vesting schedule suggests a multi-year outlook for the executive's continued engagement.

Industry Context

StockSavvy.ai notes that grants of stock options to senior management are a common practice in the technology and healthcare sectors, including medical device companies like Stereotaxis, Inc., to incentivize performance and retain talent.

Stakeholder Impact

• Shareholders: The grant aligns executive incentives with potential stock price appreciation, but the dilutive effect of future share issuance upon exercise should be considered.
• Employees: May indicate a stable management structure, but the direct impact is limited to the executive receiving the grant.
• Management: Reinforces the compensation structure for key executives.

Next Steps

• Kimberly R. Peery will continue to vest in the granted stock options over the next four years.
• The company's stock performance will determine the ultimate value and exercise of these options.

Key Dates

Keywords

Stock Options, Insider Trading, Executive Compensation, Stereotaxis Inc., STXS, Form 4, Securities Exchange Act, Beneficial Ownership